Although laboratory data suggest that several flavonoid subclasses are involved in glucose metabolism, limited clinical and epidemiologic data are available. The current study examined associations between habitual intake of flavonoid subclasses, insulin resistance, and related inflammatory biomarkers. In a cross-sectional study of 1997 females aged 18-76 y, intakes of total flavonoids and their subclasses (flavanones, anthocyanins, flavan-3-ols, polymeric flavonoids, flavonols, flavones) were calculated from food frequency questionnaires using an extended USDA database. Fasting serum glucose, insulin, highsensitivity C-reactive protein (hs-CRP; n = 1432), plasminogen activator inhibitor-1 (n = 843), and adiponectin (n = 1452) levels were measured. In multivariable analyses, higher anthocyanin and flavone intake were associated with significantly lower peripheral insulin resistance [homeostasis model assessment of insulin resistance; quintile 5 (Q5) to Q1 = 20.1, P-trend = 0.04 for anthocyanins and flavones] as a result of a decrease in insulin concentrations (Q5-Q1 = 20.7 mU/mL, P-trend = 0.02 anthocyanins; Q5-Q1 = 20.5 mU/mL, P-trend = 0.02 flavones). Higher anthocyanin intake was also associated with lower hs-CRP levels (Q5-Q1 = 20.3 mg/L, P-trend = 0.04), whereas those in the highest quintile of flavone intake had improved adiponectin levels (Q5-Q1 = 0.7 mg/L, P-trend = 0.01). Anthocyanin-rich foods were also associated with lower insulin and inflammation levels. No significant associations were observed for total or other flavonoid subclasses. Higher intakes of both anthocyanins and flavones were associated with improvements in insulin resistance and hs-CRP. These associations were found with intakes readily achieved in the diet. The observed reduction in insulin levels was similar to that reported previously for other lifestyle factors. Dose-response trials are needed to ascertain optimal intakes for the potential reduction of type 2 diabetes risk. J. Nutr.
Introduction
Insulin resistance is implicated in the development of type 2 diabetes, metabolic syndrome, and cardiovascular disease, with adiposity-associated inflammation thought to be a critical mediator in this relationship (1) . Several flavonoid subclasses have been associated with a reduction in risk of type 2 diabetes, as have foods and drinks rich in flavonoids, including apples, pears, tea, red wine, and berries (2) (3) (4) (5) . The flavonol and anthocyanin subclasses have also been inversely associated with biomarkers of adiposity-associated inflammation, including increased TNF-a, IL-6, and high-sensitivity C-reactive protein (hs-CRP) 5 (6) (7) (8) . Furthermore, in vitro data suggest that anthocyanins and flavanones can enhance adiponectin secretion in animal adipocyte and preadipocyte cells (9, 10) . However, although in vitro data support a mechanistic understanding of how specific flavonoids may reduce type 2 diabetes risk and inflammatory biomarkers, for example, by enhancing insulin sensitivity and secretion, protecting b-cell function, and improving glucose homeostasis through the upregulation of glutamate transporter 4 (GLUT4) gene expression (11) (12) (13) , the potential in vivo mechanisms for a protective effect have not been investigated in largescale population-based studies.
Subtle differences in chemical structure between the main subclasses of dietary flavonoids (flavonols; flavones; flavanones; flavan-3-ols and their oligomeric and polymeric forms [i.e., procyanidins]; isoflavones; and anthocyanins and other polymeric flavonoids) can alter both bioavailability and bioactivity (14, 15) , which highlights the importance of investigating each subclass individually. To date, evidence for a beneficial effect of specific flavonoids on insulin resistance comes from short-term randomized controlled trials. Intervention trials with cocoa (18 wk maximum duration) support beneficial effects for the flavan-3-ol subclass on insulin resistance (HOMA-IR = 20.7) (16) . In our recent longer-term 1-y combined flavonoid intervention (850 mg/d total flavan-3-ols and 100 mg/d isoflavones), we also observed a significant reduction in insulin resistance in postmenopausal women with type 2 diabetes after flavonoid intake (HOMA-IR = 20.3 6 0.2) (17) . Few data are available for other flavonoid subclasses, although two small berry interventions, rich in anthocyanins, reduced fasting glucose levels (13.3 6 4.5 to 9.1 6 3.0 mmol/L baseline vs. 3 mo) and hemoglobin A1c levels over 3 mo (9.3 6 2.2 to 7.5 6 1.3% baseline vs. 3 mo) and increased adiponectin levels over 5 mo (14.0 6 6.5 to 15.6 6 6.8 mg/L baseline vs. 20 wk), although the specific intakes of anthocyanins in the intervention diets were not reported (18, 19) . A strawberrycontaining beverage (39 mg/d anthocyanins) reduced postprandial plasma insulin concentrations after a high carbohydrate meal in overweight participants (20) , but an anthocyanin capsule administered for 4 wk (640 mg/d anthocyanins) had no significant effect on insulin resistance or inflammation in prehypertensive males (21) .
Therefore, we investigated the association between flavonoid subclasses and insulin resistance because, to our knowledge, no previous cross-sectional studies have examined the associations between flavonoid subclass intakes, measured using a comprehensive and up-to-date database, and markers of insulin resistance. We examined the associations between a range of flavonoid subclasses, as well as their main dietary sources, and markers of insulin resistance (HOMA-IR, glucose, and insulin) and inflammation [adiponectin, plasminogen activator inhibitor-1 (PAI-1) and hs-CRP], in a cohort of healthy females aged 18-76 y. It was hypothesized, based on previous research, that participants with high intakes of flavanones, anthocyanins, and flavan-3-ols would have lower insulin resistance compared with the participants with low intakes.
Participants and Methods
Study population. The current study used data collected from study participants in the TwinsUK registry, a nationwide registry that consists of adult twin volunteers recruited from the general population (22) . The twin registry was used for the rich source of data available with the current analysis focused on associations at an individual level and not designed to address genetic influence (23) . Informed consent was obtained from all participants, and ethical approval was gained from St. ThomasÕs Hospital Research Ethical committee. The participants included in these analyses were female, aged 18-76 y, and were a sample of the total population group who completed FFQs and were assessed clinically between 1996 and 2000. The population has been shown previously to be representative of the general population in terms of disease-related characteristics and dietary intake (24, 25) .
Assessment of biomarkers.
Venous blood samples were taken between 0800 and 1000 h after an overnight fasting. After centrifugation, samples were stored at 240°C, and all biochemical assays were completed within 6 mo of collection. Fasting serum insulin was measured by immunoassay (Abbott Laboratories) and fasting serum glucose using an enzymatic colorimetric assay (Ektachem 700 multichannel analyzer; Johnson & Johnson Clinical Diagnostic Systems). Insulin resistance was calculated using the model assessment (HOMA-IR) in which insulin resistance is (fasting insulin 3 glucose)/22.5. Participants with insulin values above clinically realistic values (400 pmol/L) or with hyperglycemia or potential type 2 diabetes (defined as glucose values >7 mmol/L) were excluded from these analyses. Fasting serum total adiponectin levels were measured with a two-site dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA; R&D Systems). Serum hs-CRP was measured by a highly sensitive automated microparticle capture enzyme immunoassay (Abbott Laboratories). Immunosorbent assay was used to measure total PAI-1 in plasma (ELISA; Biopool). Interassay and intra-assay CV were <10% throughout the range for all biomarkers. Data on inflammatory markers were not available for all of the 1997 participants who were assessed for insulin resistance (adiponectin, n = 1452; hs-CRP, n = 1432; PAI-1, n = 843).
Assessment of flavonoid intakes. Participants completed a 131-item FFQ validated in a U.K. population from which flavonoid intakes were estimated (26) . Dietary data were excluded if answers for >10 food items were left blank or the ratio of the FFQ-derived estimate of total energy intake to the participants estimated basal metabolic rate fell 2 SDs outside the mean ratio (<0.52 or >2.58) (25) . As described previously, flavonoid intakes were calculated using the updated USDA databases for the flavonoid and proanthocyanin content of food as primary data sources (27) (28) (29) . Intakes were derived for the six main flavonoid subclasses habitually consumed: 1) flavanones (eriodictyol, hesperetin, and naringenin); 2) anthocyanins (cyanidin, delphinidin, malvidin, pelargonidin, petunidin, and peonidin); 3) flavan-3-ols (catechins and epicatachins); 4) flavonols (quercetin, kaempferol, myricetin, and isohamnetin); 5) flavones (luteolin and apigenin); and 6) polymers (including proanthocyanidins, theaflavins, and thearubigins). Total flavonoid intakes were derived by the addition of the six component subclasses.
Assessment of covariates. Intake of energy and other nutrients were determined from the FFQ. Height was measured to the nearest 0.5 cm with the use of a wall-mounted stadiometer, weight (light clothing only) was measured to the nearest 0.1 kg with digital scales, and these data were used to derive BMI (in kilograms per square meter). Information on family medical history, medication use, lifestyle, and demographic variables were obtained by a standardized nurse-administered questionnaire. Physical activity was classified as inactive, moderate, and active during work, home, and leisure time using a validated questionnaire (30) .
Statistical analyses. Statistical analyses were performed with Stata statistical software version 11.0 (StataCorp). The current analysis treated twins as individuals, with SEs adjusted using the robust regression cluster option in Stata to take into account the dependence between individuals within a twin pair. Values presented in the text are means (95% CIs) unless otherwise stated. Quintiles of the subclasses of flavonoids were calculated, and statistical differences in outcomes were evaluated between these groups using ANCOVA. When significant associations were observed, we conducted additional analyses to evaluate which individual flavonoids were associated with our outcomes measures. To provide food-based dietary guidance, we also calculated the main dietary sources of these subclasses. Intakes of foods that contributed significantly to each of the subclasses (at least 10%) were calculated for each participant in portions per day, and these were combined to calculate total intake of foods rich in a particular subclass. For example, portions of wine, pears, berries, and grapes were grouped together to calculate total intake of anthocyanin-rich foods. Participants were then categorized according to their intake into the following groups: 1) zero portion; 2) one portion; 3) two portions; 4) three portions; and 5) four or more portions. Differences in outcome variables were assessed between these groups using ANCOVA. Foods listed as composite items on the FFQ included wine (red and white wine), grapes (red and green grapes), berries (strawberries and raspberries), peppers (red, green, and yellow peppers), and fruit juice (orange and apple juice). The distributions of all outcome measures were skewed, and therefore natural log-transformed values were used in all subsequent analyses.
All models were adjusted for age (years), current smoking (yes or no), physical activity (inactive, moderately active, or active), BMI (kilograms per square meter), menopausal status (premenopausal or postmenopausal), use of hormone replacement therapy (yes or no), use of diabetes or cholesterol-lowering drugs (yes or no), use of vitamin supplements (yes or no), and intake of energy (kilocalories per day in quintiles), carbohydrate (percentage energy in quintiles), whole grains (grams per day in quintiles), unsaturated/saturated fat ratio (quintiles), and alcohol (grams per day).
Results
Of the 5119 participants who completed an FFQ, 36% (n = 1857) were excluded for having an incomplete FFQ or implausible energy intake, 24% (n = 1211) did not attend a clinical session for insulin resistance assessment, and 1% (n = 54) had insulin values outside the inclusion criteria for the current analyses. The characteristics of the included 1997 female participants are presented in Table 1 . The sample contained 960 twin pairs and 77 isolated single twins. The mean age of the participants was 47.1 y (IQR: 39-56), and mean BMI was 25.2 kg/m 2 (IQR: 22.1-27.3). Eighteen percent of the participants were current smokers, 21% were physically inactive, and almost 50% of the participants were postmenopausal, with 17% currently using hormone replacement therapy. After excluding participants with high glucose levels (n = 44), few remaining participants were on cholesterol-lowering or diabetes medications (2%).
Mean total flavonoid intake was 1.2 g/d (IQR: 0.6-1.7), and polymeric flavonoids (including proanthocyanidins, theaflavins, and thearubigins) made the greatest contribution to total intake (73%), followed by the flavan-3-ol subclass (20%). Overall, tea was the main source of total flavonoid (81%), flavan-3-ol (91%), flavonol (63%), and polymer (83%) intake. Four foods contributed >10% of anthocyanin intake (grapes, 20%; pears, 24%; wine, 22%; and berries, 12%) and three foods to >10% of flavone intake (oranges, 27%; wine, 26%; and peppers, 14%).
In multivariable analysis, a higher intake of anthocyanins was associated with significantly lower insulin resistance as a 1.1, 1.3) . Fasting insulin levels across quintiles of anthocyanin intake were 6.7 (95% CI: 6.3, 7.1), 6.5 (95% CI: 6.1, 6.9), 5.9 (95% CI: 5.6, 6.3), 6.3 (95% CI: 6.0, 6.7), and 6.1 (95% CI: 5.7, 6.4). A higher intake of anthocyanins was also associated with a significant reduction in hs-CRP levels (Q5-Q1 = 20.3 mg, P-trend = 0.02). hs-CRP levels were 1.8 (95% CI: 1.6, 2.0), 1.6 (95% CI: 1.5, 1.8), 1.5 (95% CI: 1.3, 1.7), 1.6 (95% CI: 1.5, 1.8), and 1.5 (95% CI: 1.3, 1.7) across increasing quintiles of anthocyanin intake. For the flavone subclass, participants with the highest intakes had lower HOMA-IR and insulin levels and higher adiponectin levels, with respective differences of 20.1 (P-trend = 0.04), 20.5 mU/mL (P-trend = 0.02), and 0.6 mg/L (P-trend = 0.01) comparing extreme quintiles of intake.
Within the anthocyanin subclass (cyanidin, delphinidin, malvidin, pelargonidin, petunidin, and peonidin), delphinidin, malvidin, and petunidin were inversely associated with HOMA-IR (delphinidin Q5-Q1 = 20.1, P-trend = 0.02; malvidin Q5-Q1 = 20.1, P-trend = 0.01; and petunidin Q5-Q1 = 20.1, P-trend = 0.04) and insulin (delphinidin Q5-Q1 = 20.6, P-trend = 0.01; malvidin Q5-Q1 = 20.7, P-trend < 0.01; and petunidin Q5-Q1 = 20.7, P-trend = 0.01) ( Table 3) . For the individual flavones (luteolin and apigenin), no significant associations were observed.
In confirmatory food-based analyses, intakes of foods rich in anthocyanins were also inversely associated with both HOMA-IR and insulin (Fig. 1) . When comparing participants who consumed more than four portions of anthocyanin-rich foods per day with nonconsumers, HOMA-IR was 20.2 lower (P-trend = 0.01), and insulin decreased by 21.2 mU/mL (Ptrend < 0.01). Furthermore, there appeared to be a doseresponse relation, for example, compared with participants consuming more than four portions per day, insulin was 0.4, 0.7, and 1.2 mU/mL higher in participants consuming two, one, or no portions of anthocyanin-rich foods per day, respectively. Similar results were observed for the inflammatory biomarkers with differences of 0.8 mg/L in adiponection (P-trend = 0.02) and 20.5 mg/L in hs-CRP (P-trend = 0.02) comparing participants consuming greater than four portions per day with nonconsumers. For flavone-rich foods, similar differences were observed in HOMA-IR, insulin, and adiponection (20.2, P-trend = 0.02; 21.1 mU/mL, P-trend < 0.01; and 0.7 mg/L, P-trend = 0.03, respectively) when comparing participants who consumed more than four portions per day with nonconsumers.
Discussion
In this cross-sectional study, we observed that a higher intake of anthocyanins was associated with significantly lower insulin resistance (HOMA-IR = 20.1) as a result of a decrease in insulin concentrations (20.7 mU/mL). In the participants in whom hs-CRP was analyzed (n = 1432), we also observed significantly lower hs-CRP levels with higher intake of anthocyanins (20.3 mg/L). Flavone intake was also associated with insulin resistance (HOMA-IR = 20.1), insulin (21.5 mU/mL), and adiponectin (0.7 mg/L) concentrations. In confirmatory food-based analyses, we observed similar associations between the main dietary sources of anthocyanins and HOMA-IR (20.2), insulin (21.2 mU/mL), The findings of the current study provide an insight into the potential mechanisms by which anthocyanins may act to reduce type 2 diabetes risk and are consistent with previous studies investigating intake of specific flavonoid subclasses and type 2 diabetes risk. In particular, a recent prospective study reported a 15% reduction in risk of type 2 diabetes when comparing the highest with lowest quintiles of anthocyanin intake and a 23% reduction in risk with increased intake of blueberries (>2/wk vs. <1/mo) and apples/pears ($5/wk vs. <1/mo) (5). They are also consistent with a food-based Finnish study of >10|000 men and women that reported a reduction in risk of type 2 diabetes of 27% for apples and 26% for berries when comparing extreme quintiles of intake (2). However, our findings are in contrast to findings from the Iowa WomenÕs Health Study that reported that flavonoid consumption was not associated with diabetes risk after multivariable adjustment (4) and with findings from the Framingham Offspring cohort that showed flavonol intake, but not anthocyanin intake, was associated with lower incidence of type 2 diabetes (31).
To our knowledge, there are limited previous reports on associations between habitual flavonoid subclass intakes and markers of insulin resistance, although one dietary intervention of anthocyanin-rich foods did observe a reduction in plasma insulin concentrations (20) . Our findings are also supported by mechanistic data from animal studies suggesting that dietary anthocyanins and their degradation products/metabolites suppress proinflammatory cytokine production (32) and modulate GLUT4 and retinol binding protein 4 expression (11) . In a fructose-fed hamster model, flavone intervention reduced insulin concentrations and improved glucose tolerance through adipocytokine regulation, including increased serum adiponectin (33) . Flavones have also been shown to stimulate adipocyte differentiation and enhance glucose transport in adipocytes by inducing the PPARg-mediated expression of adiponectin and translocation of GLUT4 in 3T3-L1 adipocytes (34) .
The findings provide evidence to suggest that habitual intakes of anthocyanins are associated with inflammatory biomarkers involved in the regulation of glucose homeostasis, b-cell function, and insulin signaling, although we only observed significant associations of anthocyanins and flavones on hs-CRP and adiponectin levels, respectively (1, 35) . Interestingly, in an in vitro model, treatment of human adipocytes with anthocyanins upregulated adiponectin gene expression and downregulated PAI-1 gene expression (36) . A previous study assessing associations between flavonoid intake and inflammatory biomarkers reported that total flavonoids, flavanones, and flavones were inversely associated with IL-18 concentrations and that flavonols were inversely associated with soluble vascular cell adhesion molecule concentrations, with no significant associations reported for anthocyanin intake (8).
We did not observe an association between higher intakes of flavan-3-ols and markers of insulin resistance or inflammation, which is in agreement with a previous epidemiologic study (5) that is in contrast to our meta-analysis of flavan-3-ol randomized controlled trials in which we observed a reduction in HOMA-IR (20.7) (16). The reported doses of flavan-3-ols in these intervention studies were up to 112 mg/d, whereas mean habitual intake in our study was 24 mg/d (IQR: 15.8-33.7), and it is likely that the large differential in dose explains the lack of associations in our study. Although these findings are from cross-sectional data and require confirmation in trials, the clinical relevance is highlighted by the 0.7 mU/mL difference in insulin observed between the top and bottom quintiles of anthocyanin intake (equivalent to 35 mg of anthocyanin intake). A one unit increase in BMI has been associated previously with a 0.5 mU/mL increase in fasting insulin in women (37), a low-fat dietary intervention for 1 y decreased insulin by 0.7 mU/mL (38) , and an increase of 20 metabolic equivalent hours of physical activity per week (equivalent to 1 h of walking per day) has been associated with 0.7 mU/ mL decrease in fasting insulin (39) . The differences in HOMA-IR of 0.1 or 10% between the lowest and highest intakes of habitual anthocyanin intakes are lower than the differences reported previously for cocoa and chocolate interventions (16) . However, it is plausible that increasing intakes of anthocyanin-rich foods, such as grapes, berries, and wine, would lead to greater improvements in insulin resistance because in vitro studies have shown previously that this is dose-dependent relation (40) .
The differences in anthocyanin and flavone intakes between extreme quintiles of intake were 35 and 3.6 mg respectively. An intake of 35 mg of anthocyanins can be readily incorporated into the diet by consuming dietary relevant levels of anthocyanin-rich foods, including approximately one portion of grapes (78 g) or berries [including strawberries (105 g), raspberries (90 g), blueberries (21 g), and blackberries (39 g) ]. It was intriguing to find associations with habitual flavone intakes and our endpoint measures given the low levels of intake in population studies, with 3.6 mg of flavones being equivalent to the levels found in ;2.5 oranges (120 g each).
The strengths of the current study include the large sample size and the range of flavonoid subclasses investigated. Dietary flavonoid intakes were calculated from a database developed using the most recent USDA databases (27, 28) , with additional input from other sources. These datasets allowed us to quantify a broad range of flavonoid subclass intakes more robustly than previous analyses. The FFQ used in the current study was validated previously and shown to both reflect habitual dietary intake and have the ability to rank participants according to their usual intake of flavonoid-rich foods (26, 41) . It was notable that the associations observed in the current analysis were found after exclusion of participants with high glucose levels (>7 mmol/ L) because it is plausible that the associations would have been more pronounced if participants with diabetes had been included. Our participants are representative of the UK general population in terms diet and lifestyle (24, 25) , and these data has been used in previous studies of dietary exposure (42) . Although HOMA-IR is an indirect measure of insulin resistance, it correlates well with scores obtained from euglycemic hyperinsulinemic clamp tests and is a reliable measure of in vivo insulin resistance (43) .
The limitations of the current study include the crosssectional design that meant we were unable to infer causality. The inclusion of twin pairs within the same sample may introduce bias, but this was reduced by accounting for the clustering within twin pairs in all statistical analyses and using a sample shown to be representative of the general population in terms of outcome variables and dietary intake. High flavonoid intakes may be representative of a healthy lifestyle in general, and although we adjusted for a range of dietary and lifestyle confounder variables (such as age, smoking, physical activity, BMI, medication use, and intake of other nutrients), residual or unmeasured confounding cannot be ruled out. Although our study was hypothesis driven, on the basis of previous epidemiologic, mechanistic, and trial data, these findings need to be confirmed in future analysis. The USDA food composition 
Anthocyanins Cyanidin databases used in the current analysis allowed us to quantify a broad range of flavonoid subclass intakes, but there is wide variability in the flavonoid content of foods depending on geographical origin, growing season, different cultivars, agricultural methods, and processing. Despite this variation, our data allow us to rank order intakes and compare high and low intakes in our large group of women. There is currently a lack of validated biomarkers to integrate intake with the extensive metabolism these compounds undergo in vivo, so our current knowledge of their relative importance to health can only be derived from dietary intake data. Furthermore, TNF-a and IL-6 are inflammatory biomarkers that have been associated with insulin resistance, but these data were not available for a large number of our participants.
In conclusion, our novel data provide mechanistic support for the previously observed association between anthocyanin intake and type 2 diabetes mellitus risk (5) and suggest a beneficial role for increased intake of anthocyanins and flavones on HOMA-IR and hs-CRP concentrations. The magnitude of association is similar to those reported previously for BMI, a low-fat diet, and physical activity (37) (38) (39) . These results are of public health importance because the intakes associated with these findings are easily achievable through the habitual diet and make a significant contribution to the knowledge base needed to refine the current fruit and vegetable dietary recommendations. The findings highlight the need for more dose-response intervention trials on anthocyanins and anthocyanin-rich foods for the prevention and management of type 2 diabetes.
FIGURE 1
The associations between insulin resistance and inflammatory biomarkers and intake of anthocyanin-and flavone-rich foods (in portions per day) in 1997 females aged 18-76 y. Bars represent the percentage differences in outcome measures between participants in group 1 (zero portions per day) and group 5 (four or more portions per day); n = 1997. Portions of anthocyanins are total portions of wine (125 mL), pears (170 g), grapes (80 g), and berries (100 g). Portions of flavones are total portions of wine (125 mL), oranges (120 g), and sweet peppers (80 g). For subset analyses: adiponectin, n = 1452; hs-CRP, n = 1432; PAI-1, n = 843 participants. *P-trend based on log concentrations ,0.05 (ANCOVA age, current smoking, physical activity, BMI, menopausal status, use of hormone replacement therapy, use of diabetes or cholesterollowering drugs, use of vitamin supplements, and intake of energy, carbohydrates, whole grains, unsaturated/saturated fat ratio, and alcohol as covariates). hs-CRP, high-sensitivity C-reactive protein; PAI-1, plasminogen activator inhibitor.
